Literature DB >> 3633213

Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice.

L D Fraker, S A Halter, J T Forbes.   

Abstract

Retinoids have been shown to inhibit the growth and development of neoplastic cells in many systems. One mechanism of action may be through activation of the immune system, specifically natural killer (NK) cell activity. The effect of retinol on NK cell cytotoxicity was examined in three groups of mice: BALB/c (wild-type), BALB/c nu/nu (athymic), and BALB/c nu/nu previously injected with human tumor cells. In untreated mice, NK activity was highest in athymic mice without tumors and lowest in wild-type mice, although serum and liver retinol concentrations were identical in all three groups. In mice fed graded, nontoxic doses of retinol daily for 3 weeks, serum retinol levels in all three groups exhibited a sharp peak and decline following daily bolus retinol administration. Retinol stores in the livers showed a dose-dependent increase in all treated animals. However, NK cell activity, differed for each group. Athymic mice without tumors exhibited no change in NK activity as a result of retinol treatment. Athymic mice with tumors had NK levels that tended to increase with increasing retinol doses, but these changes were not statistically significant. Wild-type mice, on the other hand, demonstrated significantly higher NK levels after treatment with retinol doses of 300 and 600 micrograms/day. In subsequent time course experiments, there was a peak in NK activity 1 h following bolus retinol administration similar to the peak seen in serum retinol concentrations, suggesting either an acute activation or recruitment of cytotoxic cells. Retinol thus appears to increase NK activity in wild-type BALB/c mice, and this activity may be an important component of its antineoplastic activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3633213     DOI: 10.1007/BF00199858

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  30 in total

1.  Vitamin A: adjuvant and steroid antagonist in the immune response.

Authors:  B E Cohen; I K Cohen
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

2.  Breast tumor cell lines from pleural effusions.

Authors:  R Cailleau; R Young; M Olivé; W J Reeves
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

3.  Fluorometric determination of vitamin A in human blood and liver.

Authors:  J N Thompson; P Erdody; R Brien; T K Murray
Journal:  Biochem Med       Date:  1971-02

4.  Effect of retinoic acid on the spontaneous and interferon-induced activity of human natural killer cells.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

Review 5.  Vitamin A and retinoids in health and disease.

Authors:  D S Goodman
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

Review 6.  Vitamin A and cancer.

Authors:  D E Ong; F Chytil
Journal:  Vitam Horm       Date:  1983       Impact factor: 3.421

7.  Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.

Authors:  Y Tomita; K Himeno; K Nomoto; H Endo; T Hirohata
Journal:  J Natl Cancer Inst       Date:  1982-05       Impact factor: 13.506

8.  Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

Authors:  B M Vose; F Vánky; E Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

9.  Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.

Authors:  M Takasugi; A Ramseyer; J Takasugi
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

10.  Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice.

Authors:  L D Fraker; S A Halter; J T Forbes
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

View more
  3 in total

1.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Authors:  C L Arteaga; S D Hurd; A R Winnier; M D Johnson; B M Fendly; J T Forbes
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.

Authors:  Sohji Nishina; Akira Yamauchi; Takumi Kawaguchi; Kohei Kaku; Moritaka Goto; Kyo Sasaki; Yuichi Hara; Yasuyuki Tomiyama; Futoshi Kuribayashi; Takuji Torimura; Keisuke Hino
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-09-11

3.  Retinoids, breast cancer and NK cells.

Authors:  M L Villa; E Ferrario; D Trabattoni; F Formelli; G De Palo; A Magni; U Veronesi; E Clerici
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.